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FORMALDEHYDE FROM E-CIGARETTES—IT’S
NOT AS SIMPLE AS SOME SUGGEST
In their communication here [1], and previously in the
New England Journal of Medicine [2], Bates & Farsalinos
(referred below to as B&F) make numerous assertions
and assumptions that are not supported by facts. We
address these as follows:
B&F:‘The authors had rigged up a battery and atomiser
combination that when operated at a higher voltage
setting wouldmean the atomiser ran very hot and con-
stituents in the liquid would create thermal decomposi-
tion products, including formaldehyde. The flaw in the
experiment is that under these conditions the vapour
tastes so acrid and harsh that human users will not in-
hale it …’
Response: (a) Use of the term ‘rigged up’ sug-
gests that we established makeshift or special
conditions to make the tests, when in fact we used
a commercial e-cigarette device with available power
settings; (b) regarding the statement that ‘in our
experiments the atomiser ran very hot’, all e-
cigarette coils necessarily reach high temperatures
to create the aerosol(s) of propylene glycol and/or
glycerol that form the basis of most e-cigarette liquids.
That the conditions used were not relevant to real
users is ipso facto false, given that we used a commercial
device at available settings, notwithstanding the specu-
lations of B&F regarding how the vaped aerosols we
evaluated would have tasted to anyone; and (c)
B&F are entitled to speculate that use of the higher
power setting in our work constituted ‘overheating’,
and led necessarily to vapour characteristics for all
humans (and e-cigarette fluids used) of ‘acrid’,
‘harsh’, and non-inhalable. However, that view
seems highly tenuous, especially because of the very
high concentrations of flavor chemicals we have
found in many e-cigarette fluids [3]. In fact, the to-
bacco industry has used flavorants to overcome
smoke that is ‘acrid’ and ‘harsh’ for many years [4–6].
B&F:‘It would have been reasonable for the authors to
conclude that under certain conditions, overheating
of the atomiser could result in high levels of formalde-
hyde that could pose a risk to users…’
Response:B&F are welcome to speculate about
‘overheating’, etc. However, in our Letter [7] we have
presented only facts as we found them. We stated
clearly that we did not detect the formaldehyde-
containing compound when we ran the tests at the
lower power setting, and saw it at high levels only at
the higher power setting that was available on the
commercial device that we used.
B&F:‘…but to engage in the kind of health impact
modelling exercise they did and to report the results
so prominently without the required caveats, in our
view, is likely to mislead readers and judging from
many of the headlines, this is indeed what happened’.
Response:Calculations of cancer risk based on
established cancer slope factors are the internation-
ally accepted basis for cancer risk estimates and corre-
sponding regulatory actions. As just one example,
using the same cancer slope factor as employed in
our work, Pilidis et al. [8] computed predicted numer-
ical cancer risk values due to formaldehyde in indoor
and outdoor air in urban Ioannina, a medium-sized
(100000 inhabitants) city in northwestern Greece.
Further, despite what B&F imply, our Letter clearly
makes the comparison only for formaldehyde in ciga-
rettes versus formaldehyde in e-cigarettes and, for the
latter, as used only at the higher power setting we
employed. We also emphasized these points in our
earlier reply Letter in the New England Journal of
Medicine [9].
Regardless of how extensively they may be regulated,
and how useful they will be in reducing smoking, it is clear
that electronic nicotine delivery systems (ENDSs) are here
to stay. Less clear are the extents to which this technology
may be safer than habitual use of tobacco products, and
whether ENDSs may, by themselves, lead to dependence
on nicotine as well as, unfortunately, other ‘vapable’
addictive drugs.
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E-CIGARETTES NEED TO BE TESTED FOR SAFETY
UNDER REALISTIC CONDITIONS
In our view, Pankow et al. have not addressed adequately
the key criticism of their report: that they used results
from laboratory tests of e-cigarettes under conditions that
rarely occur in practice to calculate a human cancer risk.
Pankow et al. did not counter the point that their exper-
iment created the well-recognized, and very unpleasant,
‘dry puff ’ phenomenon, when the power input and
atomizer combination causes high temperatures that
create a very unpleasant taste so that users avoid this
combination [1–3]. Farsalinos et al. [4] have confirmed
that aldehydes are contained in the aerosol at high levels
only under these ‘dry-puff ’ conditions. The point is that
users limit their exposure to dry puff conditions by
adjusting the power input, puff depth and frequency
and liquid flow to ensure that they avoid this unpleasant
experience, whatever the combination of battery and at-
omizer used. An experiment that overlooks this human
control feedback cannot provide reliable data on human
exposures.
Pankow et al. argue that flavours would mask the
acrid taste of the dry puff; but this is speculation,
and contradicted by the fact that the phenomenon is
reported by e-cigarette users who are using flavoured
e-liquid. Moreover, flavours in e-cigarettes are not
added to mask any harsh and unpleasant taste but
because flavourless e-liquids are bland and boring.
The authors’ conclusions, together with a press release
from the New England Journal of Medicine, predictably
created a misleading impression of the harmfulness of
e-cigarettes.
For the future, we recommend that tests of the safety
of e-cigarettes in laboratory conditions be accompanied
by user tests to assess how likely it is that those
conditions would arise in practice, and that researchers
exercise appropriate caution when generalizing their
findings.
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